Astec Lifesciences reports consolidated net loss of Rs 38.56 crore in the September 2024 quarter

Net Loss of Astec Lifesciences reported to Rs 38.56 crore in the quarter ended September 2024 as against net loss of Rs 13.43 crore during the previous quarter ended September 2023. Sales declined 11.05% to Rs 98.55 crore in the quarter ended September 2024 as against Rs 110.79 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	98.55	110.79	-11
OPM %	-20.03	-3.09	-
PBDT	-27.07	-8.44	-221
PBT	-38.54	-17.60	-119
NP	-38.56	-13.43	-187